TGen News & Press Releases

TGen-led study tracks infection and immunity across the universe of human viruses over time

Posted Monday April 3, 2023

Results offer glimpse into the future of forecasting infection and immunity

PepSeq Provides Massive Platform for Antibody Analyses

Posted Monday December 5, 2022

Technology developed at TGen described in new study

COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses

Posted Tuesday July 5, 2022

Technology developed by TGen researchers could help fine-tune future vaccines

TGen works with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2, the causative agent of COVID-19 in humans

Posted Monday May 16, 2022

Program helps ensure animals and the general public are protected from SARS-Cov-2 and serves as a model for monitoring other zoonotic diseases in the future

TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID

Posted Tuesday May 3, 2022

Arizona COVID-19 Genomics Union positions state to play a role in CDC’s national pathogen genomics strategy

TGen’s annual economic impact on Arizona exceeds half a billion dollars

Posted Tuesday November 30, 2021

Latest economic-impact report shows that TGen returns $132 for every $1 invested by the State of Arizona

TGen case study documents first reported U.S. transmission of COVID from a pet owner to pets

Posted Monday November 1, 2021

Using precision genomic sequencing, TGen matched the exact strain of coronavirus shared among a Phoenix-area owner, his cat and his dog

Citizen-scientist study fuels launch of first interactive U.S. county map of ticks carrying diseases

Posted Wednesday October 20, 2021

Study finds ticks carrying disease-causing bacteria in 116 U.S. counties where they have not been previously documented by CDC

TGen looks beyond COVID-19 as it advances pathogen sequencing

Posted Thursday July 15, 2021

Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold

Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID-19

Posted Wednesday July 14, 2021

Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseases

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen